Oakville, Canada

Michael Bardeleben

This inventor holds 14 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignee: Dana Canada Corporation. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Bardeleben. Retrieved from https://idiyas.com/inventor/michael-bardeleben

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 71.4

 

 

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Michael Bardeleben - Innovative Inventor from Oakville, CA

Introduction: Michael Bardeleben is a renowned inventor based in Oakville, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Michael Bardeleben holds several patents in the fields of technology, healthcare, and sustainability, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Michael Bardeleben has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Michael Bardeleben has collaborated with leading companies, research institutions, and universities to bring his ideas to life, fostering a culture of creativity and forward thinking.

Conclusion: Michael Bardeleben's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…